Up-to-date news about Intravacc

Stay informed about the latest developments in our mission to pioneer transformative vaccines with up-to-date corporate communications. Get the latest news on our development and business milestones, as well as industry insights, partnership announcements, and corporate reports.

press 17Category icon

CEPI partners with Intravacc to develop an intranasal, broadly protective Betacoronavirus vaccinee

Category icon

Intravacc announces additional favorable preclinical and toxicology data for Avacc 10®, an intranasal SARS-CoV-2 candidate vaccine

Annual Report 2021Category icon

Intravacc publishes 2021 Annual Report and announces expansion of its management team and board of directors

Category icon

Intravacc signs an exclusive license agreement with Zhifei Lvzhu Biopharmaceutical to commercialize Avacc 3

Contact us

You can send us an email:

Reach out to Business Development:

Or pick up the phone: 
+31 30 792 03 00

You can also just fill out the contact form on the right.

We look forward to hearing from you!


Contact form

Subscribe to our newsletter